News & Perspective

Apr 03, 2019

Apr 03, 2019

News Scan for Apr 03, 2019

Ebola Bombali in Kenyan bats
Universal flu vaccine trial
E coli O103 in 4 states
Lassa fever in Nigeria
Waterborne hospital infections

Feb 08, 2019

Feb 08, 2019

ASP Scan (Weekly) for Feb 08, 2019

Inadequate TB drug-susceptibility testing
New UK guidance on antibiotics for acute cough
FDA to review new Merck antibiotics
CARB-X novel antibiotic funding
Antibiotic prescribing intervention in China
Candida auris fungemia
Microbiology test use in Norway
CRP-guided therapy
Formulary restriction policy
New CARB-X funding
Feb 08, 2019

Stewardship / Resistance Scan for Feb 08, 2019

Inadequate TB drug-susceptibility testing
New UK guidance on antibiotics for acute cough

Sep 28, 2018

Sep 28, 2018

News Scan for Sep 28, 2018

Funds for MERS, Lassa, Nipah vaccines
New polio cases

Aug 30, 2018

Aug 30, 2018
Polio vax Nepal

Study reveals early impact of 3-strain oral polio vaccine withdrawal

The study provides evidence that population immunity is critical for the successful phase-out of oral polio vaccines.

Apr 10, 2018

Apr 10, 2018

News Scan for Apr 10, 2018

Superbugs in nursing homes
Lassa fever continues
Malaria net effectiveness

Feb 27, 2018

Feb 27, 2018

News Scan for Feb 27, 2018

Lassa fever in Nigeria
Kenya chikungunya outbreak
Spread of resistant Pseudomonas

Aug 13, 2014

Aug 13, 2014
MSF Ebola center

Countries take more control steps as Ebola totals grow

From travel-related measures to the offer of experimental vaccine, African and non-African nations take steps to control spread.

Jul 05, 2012

Jul 05, 2012

Study maps zoonotic disease burden, hot spots

(CIDRAP News) – A review and mapping study to gauge the burden of zoonotic diseases found that Ethiopia, Nigeria, Tanzania, and India are four top hot spots and that a surging demand for livestock products will likely fuel the spread of several diseases.

Pages

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»